![Karen Ferrante](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen Ferrante
Directeur/Membre du Conseil chez
COGENT BIOSCIENCES, INC.
Fortune : 58 853 $ au 31/08/2026
Profil
Dr. Karen J.
Ferrante, MD, is an Independent Director at Cogent Biosciences, Inc. She is on the Board of Directors at Cogent Biosciences, Inc. and New England Women In Science Executives Club.
Dr. Ferrante was previously employed as an Independent Non-Executive Director by HUTCHMED (China) Ltd., an Independent Director by MacroGenics, Inc., an Independent Director by Baxalta, Inc., a Chief Medical Officer, Head-Research & Technology by Tokai Pharmaceuticals, Inc., an Independent Director by Progenics Pharmaceuticals, Inc., a Head-Oncology Therapeutic Area by Takeda Oncology Co., a Head-Oncology Therapeutic Area by Takeda Pharmaceutical Co., Ltd., a Vice President-Oncology Development by Pfizer Inc., an Associate Director by Bristol Myers Squibb Co., and a Vice President-Oncology Department by Pfizer (St. Louis).
She received her undergraduate degree from Providence College and a doctorate degree from Georgetown University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MACROGENICS, INC. 0,02 % | 19/05/2026 | 14 750 ( 0,02 % ) | 58 853 $ | 31/08/2026 |
| 01/07/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Karen Ferrante
| Sociétés | Poste | Début |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Directeur/Membre du Conseil | 01/02/2018 |
New England Women In Science Executives Club
 New England Women In Science Executives Club Miscellaneous Commercial ServicesCommercial Services Operates as a women's club which allows members to discuss their challenges, solutions and ideas | Directeur/Membre du Conseil | - |
Anciens postes connus de Karen Ferrante
| Sociétés | Poste | Fin |
|---|---|---|
| MACROGENICS, INC. | Directeur/Membre du Conseil | 01/09/2026 |
| HUTCHMED (CHINA) LIMITED | Directeur/Membre du Conseil | 12/05/2023 |
| PROGENICS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 19/06/2020 |
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel proprietary therapies for the treatment of prostate cancer and other hormonally driven diseases | Directeur Technique/Scientifique/R&D | 31/08/2016 |
| BAXALTA INC | Directeur/Membre du Conseil | 03/06/2016 |
Formation de Karen Ferrante
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
HUTCHMED (China) Ltd.
 HUTCHMED (China) Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products | Health Technology |
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
Providence College
 Providence College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel proprietary therapies for the treatment of prostate cancer and other hormonally driven diseases | Health Technology |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
New England Women In Science Executives Club
New England Women In Science Executives Club Miscellaneous Commercial ServicesCommercial Services Operates as a women's club which allows members to discuss their challenges, solutions and ideas | Commercial Services |
